Patient-reported outcomes and realistic clinical endpoints for JAK inhibitors in rheumatoid arthritis.
Article in Expert Review of Clinical Immunology (March 2022)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 24,135 Patients
Article in International Journal of Molecular Sciences (January 2022)
Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials
Article in Rheumatology and Therapy (January 2022)